These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1865967)

  • 21. CBF and oxygen metabolism in hemodialysis patients: effects of anemia correction with recombinant human EPO.
    Hirakata H; Yao H; Osato S; Ibayashi S; Onoyama K; Otsuka M; Ichiya Y; Kuwabara Y; Masuda Y; Fujishima M
    Am J Physiol; 1992 May; 262(5 Pt 2):F737-43. PubMed ID: 1590418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effects of recombinant human erythropoietin on macro- and microcirculation in chronic hemodialysis patients.
    Wirtz JJ; Leunissen KM; van Kuijk W; Cheriex EC; Slaaf DW; Reneman RS; van Hooff JP
    Blood Purif; 1993; 11(4):237-47. PubMed ID: 8297565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic mechanism of the elevation in blood pressure following the improvement of anemia with recombinant human erythropoietin.
    Kamata K; Marumo F; Onoyama K
    Jpn Circ J; 1991 Jul; 55(7):649-56. PubMed ID: 1880896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of the 6-month anemia therapy with erythropoietin on renal function and some hemodynamic parameters in predialysis patients.
    Tomczak-Watras W; Strózecki P; Zuchora Z; Szefer J; Manitius J
    Pol Arch Med Wewn; 2009; 119(1-2):45-51. PubMed ID: 19341178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients.
    Frank H; Heusser K; Höffken B; Huber P; Schmieder RE; Schobel HP
    Kidney Int; 2004 Aug; 66(2):832-40. PubMed ID: 15253740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved physical performance after treatment of renal anemia with recombinant human erythropoietin.
    Braumann KM; Nonnast-Daniel B; Böning D; Böcker A; Frei U
    Nephron; 1991; 58(2):129-34. PubMed ID: 1865966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correction of amino acid metabolism by recombinant human erythropoietin therapy in hemodialysis patients.
    Riedel E; Hampl H; Scigalla P; Nündel M; Kessel M
    Kidney Int Suppl; 1989 Nov; 27():S216-21. PubMed ID: 2636662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy of renal anemia in children and adolescents with recombinant human erythropoietin (rHuEPO).
    Campos A; Garin EH
    Clin Pediatr (Phila); 1992 Feb; 31(2):94-9. PubMed ID: 1544282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant-human erythropoietin.
    Schwartz AB; Prior JE; Mintz GS; Kim KE; Kahn SB
    Transplant Proc; 1991 Apr; 23(2):1827-30. PubMed ID: 2053168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
    Díez J; Iglesias P; Sastre J; Méndez J; Selgas R; Gómez-Pan A
    Nephron; 1996; 74(3):548-54. PubMed ID: 8938679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Assessment of iron requirements during treatment of anemia with recombinant human erythropoietin in patients with chronic renal insufficiency under hemodialysis].
    Oliveira C; Boquinhas H; Gaspar A; Adragão T; Boquinhas JM; Júnior EC; Simões J
    Acta Med Port; 1992 Jul; 5(7):351-7. PubMed ID: 1442178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of renal anemia with recombinant human erythropoietin].
    Burghard R; Gordjani N; Leititis JU
    Monatsschr Kinderheilkd; 1989 Mar; 137(3):174-7. PubMed ID: 2716749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of erythropoietin on the cardiovascular system and the intradialytic hemodynamic behavior].
    Quarello F; Martina G; Beltrame G; Boero R; Forneris G; Borca M; Iadarola GM; Stramignoni E; Maffei S; Piccoli G
    Minerva Urol Nefrol; 1991; 43(3):125-30. PubMed ID: 1817333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters.
    Kirkpantur A; Kahraman S; Yilmaz R; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
    Artif Organs; 2005 Dec; 29(12):965-72. PubMed ID: 16305652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythropoiesis and erythrocyte age distribution in hemodialysis patients undergoing erythropoietin therapy.
    Hampl H; Riedel E; Scigalla P; Stabell U; Wendel G
    Blood Purif; 1990; 8(3):117-25. PubMed ID: 2244989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin, folic acid deficiency and hyperhomocysteinemia: is there a possible relationship in chronically hemodialyzed patients?
    Korzets A; Ori Y; Chagnac A; Weinstein T; Herman M; Zevin D; Malachi T; Gafter U
    Clin Nephrol; 2000 Jan; 53(1):48-54. PubMed ID: 10661482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy with recombinant human erythropoietin reduces cardiac size and improves heart function in chronic hemodialysis patients.
    Löw-Friedrich I; Grützmacher P; März W; Bergmann M; Schoeppe W
    Am J Nephrol; 1991; 11(1):54-60. PubMed ID: 1828650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folic acid supplementation improves erythropoietin response.
    Pronai W; Riegler-Keil M; Silberbauer K; Stockenhuber F
    Nephron; 1995; 71(4):395-400. PubMed ID: 8587618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of optimized heart failure therapy and anemia correction with epoetin beta on left ventricular mass in hemodialysis patients.
    Hampl H; Hennig L; Rosenberger C; Amirkhalily M; Gogoll L; Riedel E; Scherhag A
    Am J Nephrol; 2005; 25(3):211-20. PubMed ID: 15900093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exercise in hemodialysis patients after treatment with recombinant human erythropoietin.
    Lundin AP; Akerman MJ; Chesler RM; Delano BG; Goldberg N; Stein RA; Friedman EA
    Nephron; 1991; 58(3):315-9. PubMed ID: 1910154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.